Insider Transactions in Q3 2025 at Drugs Made In America Acquisition Ii Corp. (DMII)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2025
|
Catherine Do Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 26
2025
|
Myron W. Shulgan Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 26
2025
|
Glenn C. Worman CFO |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 26
2025
|
Lynn Stockwell CEO and Exe. Chair of Board |
SELL
Open market or private sale
|
Indirect |
7,966,667
-54.29%
|
-
|
|
Sep 26
2025
|
Lynn Stockwell CEO and Exe. Chair of Board |
SELL
Other acquisition or disposition
|
Indirect |
400,000
-2.65%
|
-
|
|
Sep 26
2025
|
Lynn Stockwell CEO and Exe. Chair of Board |
BUY
Open market or private purchase
|
Indirect |
700,000
+4.44%
|
-
|
|
Sep 26
2025
|
Drugs Made In America Acquisition Ii LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,966,667
-54.29%
|
-
|
|
Sep 26
2025
|
Drugs Made In America Acquisition Ii LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
400,000
-2.65%
|
-
|
|
Sep 26
2025
|
Drugs Made In America Acquisition Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
700,000
+4.44%
|
-
|
|
Sep 26
2025
|
Sridhar G. Prasad Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|